The Supreme Court on Tuesday questioned the disparity in drug pricing with essential cancer drugs sold to consumers at a whopping ₹27,000 when the price at which it is sold to retailers is only ₹2,700, observing that this amounts to “broad daylight dacoity” and asked the government authorities why they fail to act on this crucial issue
The Supreme Court on Tuesday questioned the disparity in drug pricing with essential cancer drugs sold to consumers at a whopping ₹27,000 when the price at which it is sold to retailers is only ₹2,700, observing that this amounts to “broad daylight dacoity” and asked the government authorities why they fail to act on this crucial issue
<iframe src="https://hindustansphere.com/embed/cluster/ad2f2aae0252c174297231379e061f3c8e6a1aa9" width="100%" height="320" style="border:0;max-width:680px" loading="lazy" title="Blatant daylight dacoity: SC on 10-fold gap in cancer drug prices"></iframe>
